CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | PERLROTH VICTOR Chairman and CEO | Option exercise | +314,684 | $3.95 | $1.2M | 3,676,062 |
| 2026-09-25 | PERLROTH VICTOR Chairman and CEO | Option exercise · Stock Option (Right to Buy) | −600,000 | 0 | ||
| 2026-09-25 | PERLROTH VICTOR Chairman and CEO | Option exercise · Stock Option (Right to Buy) | −365,840 | 0 | ||
| 2026-09-25 | PERLROTH VICTOR Chairman and CEO | Option exercise · Stock Option (Right to Buy) | −314,684 | 0 | ||
| 2026-07-15 | PERLROTH VICTOR Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-07-15 | BORGESON JOHN A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +66,500 | 66,500 | ||
| 2026-06-30 | Dahiyat Bassil I Director | Grant or award · Stock Option (Right to Buy) | +17,731 | 17,731 | ||
| 2026-06-30 | Bancroft Charles A Director | Grant or award · Stock Option (Right to Buy) | +17,731 | 17,731 | ||
| 2026-06-30 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +17,731 | 17,731 | ||
| 2026-06-30 | Yang Taiyin Director | Grant or award · Stock Option (Right to Buy) | +17,731 | 17,731 | ||
| 2026-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +17,731 | 17,731 | ||
| 2026-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +17,731 | 17,731 | ||
| 2026-06-30 | PROFUSEK ROBERT Director | Grant or award · Stock Option (Right to Buy) | +17,731 | 17,731 | ||
| 2026-06-04 | BORGESON JOHN A. Chief Financial Officer | Option exercise 10b5-1 | +30,000 | $1.04 | $31K | 241,930 |
| 2026-06-04 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −25,896 | $34.01 | $881K | 216,034 |
| 2026-06-04 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −4,104 | $34.67 | $142K | 211,930 |
| 2026-06-04 | BORGESON JOHN A. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 0 | ||
| 2026-04-15 | BORGESON JOHN A. Chief Financial Officer | Option exercise | +28,614 | $1.04 | $30K | 211,930 |
| 2026-04-15 | BORGESON JOHN A. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −28,614 | 30,000 | ||
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Option exercise 10b5-1 | +30,000 | $1.04 | $31K | 213,316 |
Page 6 of 20 · 388 trades